• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响烧伤患者万古霉素谷浓度的因素:一项单中心回顾性研究

Factors influencing vancomycin trough concentration in burn patients: a single center retrospective study.

作者信息

Shi Yan, Yin Zongqi, Zhang Qin, Yi Lei, Dou Yi

机构信息

Department of Burn, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.

出版信息

Front Pharmacol. 2024 Dec 12;15:1377930. doi: 10.3389/fphar.2024.1377930. eCollection 2024.

DOI:10.3389/fphar.2024.1377930
PMID:39734407
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11672795/
Abstract

OBJECTIVE

To analyze factors influencing the vancomycin trough concentration in burn patients to provide a basis for the more rational use of vancomycin in these patients.

MATERIALS AND METHODS

We collected the clinical data of adult burn patients treated with vancomycin in a Chinese hospital. Vancomycin was administered at a dosing regimen of 1.0 g q12 h. Patients were divided into a therapeutic group with vancomycin trough concentration in the target therapeutic range (10-20 μg/mL) and a subtherapeutic group with vancomycin trough concentration in the subtherapeutic range (<10 μg/mL).

RESULTS

The therapeutic group included 14 patients (17.5%), with an average trough concentration of 14.36 ± 2.82 μg/mL; the subtherapeutic group included 66 patients (82.5%), with an average trough concentration of 5.18 ± 2.77 μg/mL. The serum creatinine level was significantly higher in the therapeutic group (84.93 ± 47.26 μmol/L) than that in the subtherapeutic group (62.44 ± 14.49 μmol/L) ( < 0.01). Serum albumin levels were significantly lower in the therapeutic group (30.50 ± 2.28 g/L) than those in the subtherapeutic group (34.00 ± 6.22 g/L) ( < 0.05). Using receiver operating characteristic (ROC) curve analysis, for serum albumin, the area under the ROC curve (AUC) (95% confidence interval [CI]) was 0.67 (0.553, 0.788); the optimal cut-off point was 34.50 g/L ( = 0.046), the sensitivity was 0.379, and the specificity was 1.0. For creatinine clearance, the AUC (95% CI) was 0.72 (0.537, 0.902); the optimal cut-off point was 76.64 mL/min ( = 0.01), the sensitivity was 0.985, and the specificity was 0.5. The linear stepwise regression equation was as follows: trough concentration = 0.14 × age + 0.071 × serum creatinine -4.196.

CONCLUSION

In this study, a high proportion of burn patients had a vancomycin trough concentration below the standard range. Serum creatinine clearance and albumin levels are important indicators for predicting whether the vancomycin trough concentration is within the standard range. Using a linear stepwise regression equation, the vancomycin trough concentration can be estimated using the patient's age and serum creatinine level.

摘要

目的

分析影响烧伤患者万古霉素谷浓度的因素,为这些患者更合理使用万古霉素提供依据。

材料与方法

我们收集了一家中国医院接受万古霉素治疗的成年烧伤患者的临床资料。万古霉素给药方案为1.0 g每12小时一次。患者分为治疗组(万古霉素谷浓度在目标治疗范围10 - 20μg/mL)和亚治疗组(万古霉素谷浓度在亚治疗范围<10μg/mL)。

结果

治疗组包括14例患者(17.5%),平均谷浓度为14.36±2.82μg/mL;亚治疗组包括66例患者(82.5%),平均谷浓度为5.18±2.77μg/mL。治疗组血清肌酐水平(84.93±47.26μmol/L)显著高于亚治疗组(62.44±14.49μmol/L)(<0.01)。治疗组血清白蛋白水平(30.50±2.28 g/L)显著低于亚治疗组(34.00±6.22 g/L)(<0.05)。采用受试者工作特征(ROC)曲线分析,对于血清白蛋白,ROC曲线下面积(AUC)(95%置信区间[CI])为0.67(0.553,0.788);最佳截断点为34.50 g/L(P = 0.046),敏感性为0.379,特异性为1.0。对于肌酐清除率,AUC(95%CI)为0.72(0.537,0.902);最佳截断点为76.64 mL/min(P = 0.01),敏感性为0.985,特异性为0.5。线性逐步回归方程如下:谷浓度 = 0.14×年龄 + 0.071×血清肌酐 - 4.196。

结论

在本研究中,高比例的烧伤患者万古霉素谷浓度低于标准范围。血清肌酐清除率和白蛋白水平是预测万古霉素谷浓度是否在标准范围内的重要指标。使用线性逐步回归方程,可根据患者年龄和血清肌酐水平估算万古霉素谷浓度。

相似文献

1
Factors influencing vancomycin trough concentration in burn patients: a single center retrospective study.影响烧伤患者万古霉素谷浓度的因素:一项单中心回顾性研究
Front Pharmacol. 2024 Dec 12;15:1377930. doi: 10.3389/fphar.2024.1377930. eCollection 2024.
2
Utilization of Augmented Renal Clearance in Trauma Intensive Care Scoring System to Improve Vancomycin Dosing in Trauma Patients at Risk for Augmented Renal Clearance.在创伤重症监护评分系统中利用增强肾清除率来改善有增强肾清除率风险的创伤患者的万古霉素给药剂量。
Surg Infect (Larchmt). 2020 Feb;21(1):43-47. doi: 10.1089/sur.2019.026. Epub 2019 Jul 23.
3
[Pharmacokinetics of vancomycin in patients with severe acute pancreatitis and its influencing factors: analysis of 7 years data].[万古霉素在重症急性胰腺炎患者中的药代动力学及其影响因素:7年数据分析]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017 Jun;29(6):491-495. doi: 10.3760/cma.j.issn.2095-4352.2017.06.003.
4
[The effect of renal clearance on serum trough concentration of vancomycin in elderly patients with severe pneumonia].[肾脏清除率对老年重症肺炎患者万古霉素血药谷浓度的影响]
Zhonghua Jie He He Hu Xi Za Zhi. 2016 Feb;39(2):105-9. doi: 10.3760/cma.j.issn.1001-0939.2016.02.006.
5
Predictive performance of reported vancomycin population pharmacokinetic model in patients with different renal function status, especially those with augmented renal clearance.报告的万古霉素群体药代动力学模型在不同肾功能状态患者中的预测性能,特别是那些合并有增强的肾清除率的患者。
Eur J Hosp Pharm. 2022 Mar;29(e1):e6-e14. doi: 10.1136/ejhpharm-2020-002477. Epub 2021 Jan 7.
6
[Predictive performance of population pharmacokinetic software on vancomycin steady-state trough concentration].[群体药代动力学软件对万古霉素稳态谷浓度的预测性能]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Jan;32(1):50-55. doi: 10.3760/cma.j.cn121430-20190814-00009.
7
[Analysis of influencing factors of trough serum vancomycin concentrations in critically ill neurosurgical patients].[重症神经外科患者血清万古霉素谷浓度的影响因素分析]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 Nov;31(11):1384-1388. doi: 10.3760/cma.j.issn.2095-4352.2019.11.014.
8
The Impact of Capping Creatinine Clearance on Achieving Therapeutic Vancomycin Concentrations in Neurocritically Ill Patients with Traumatic Brain Injury.肌酐清除率上限对颅脑创伤合并神经危重症患者实现治疗性万古霉素浓度的影响。
Neurocrit Care. 2019 Feb;30(1):126-131. doi: 10.1007/s12028-018-0583-z.
9
Conversion from Vancomycin Trough Concentration-Guided Dosing to Area Under the Curve-Guided Dosing Using Two Sample Measurements in Adults: Implementation at an Academic Medical Center.从基于万古霉素谷浓度的给药方案转换为基于曲线下面积的给药方案:在成人中使用两次样本测量的实施。
Pharmacotherapy. 2019 Apr;39(4):433-442. doi: 10.1002/phar.2234. Epub 2019 Mar 18.
10
[Clinical research for trough value of serum vancomycin in critical patients].[危重症患者血清万古霉素谷浓度的临床研究]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2014 Jul;26(7):473-7. doi: 10.3760/cma.j.issn.2095-4352.2014.07.006.

本文引用的文献

1
Pharmacokinetic/pharmacodynamic parameters of vancomycin for predicting clinical outcome of enterococcal bacteremia.预测肠球菌菌血症临床结局的万古霉素药代动力学/药效学参数。
BMC Infect Dis. 2022 Aug 10;22(1):686. doi: 10.1186/s12879-022-07668-w.
2
Evaluation of Voriconazole and Posaconazole Dosing in Patients With Thermal Burn Injuries.评价伏立康唑和泊沙康唑在热烧伤患者中的剂量。
J Burn Care Res. 2022 Jul 1;43(4):802-807. doi: 10.1093/jbcr/irab200.
3
Continuous infusion versus intermittent infusion vancomycin in a burn center intensive care unit.烧伤中心重症监护病房中万古霉素持续输注与间歇输注的比较
Burns. 2021 Nov;47(7):1495-1501. doi: 10.1016/j.burns.2021.08.016. Epub 2021 Sep 3.
4
Epidemiology and outcomes of bloodstream infections in severe burn patients: a six-year retrospective study.严重烧伤患者血流感染的流行病学和结局:一项六年回顾性研究。
Antimicrob Resist Infect Control. 2021 Jun 30;10(1):98. doi: 10.1186/s13756-021-00969-w.
5
Population pharmacokinetic modeling and clinical application of vancomycin in Chinese patients hospitalized in intensive care units.万古霉素在中国 ICU 住院患者中的群体药代动力学建模与临床应用。
Sci Rep. 2021 Jan 29;11(1):2670. doi: 10.1038/s41598-021-82312-2.
6
Evidence-based Guideline for Therapeutic Drug Monitoring of Vancomycin: 2020 Update by the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society.中国药理学会治疗药物监测专业委员会《万古霉素治疗药物监测临床应用指南(2020 版)》
Clin Infect Dis. 2020 Dec 23;71(Suppl 4):S363-S371. doi: 10.1093/cid/ciaa1536.
7
Pharmacokinetics and Pharmacodynamics of Antimicrobial Agents in Burn Patients.烧伤患者中抗菌药物的药代动力学和药效学。
Surg Infect (Larchmt). 2021 Feb;22(1):77-82. doi: 10.1089/sur.2020.375. Epub 2020 Nov 6.
8
Application of vancomycin in patients with augmented renal clearance.万古霉素在肾清除增强患者中的应用。
Eur J Hosp Pharm. 2020 Sep;27(5):276-279. doi: 10.1136/ejhpharm-2018-001781. Epub 2019 Jan 9.
9
An Update on Population Pharmacokinetic Analyses of Vancomycin, Part I: In Adults.万古霉素群体药代动力学分析的最新进展,第一部分:成人篇。
Clin Pharmacokinet. 2020 Jun;59(6):671-698. doi: 10.1007/s40262-020-00866-2.
10
Correlation of the vancomycin 24-h area under the concentration-time curve (AUC) and trough serum concentration in children with severe infection: A clinical pharmacokinetic study.儿童严重感染患者万古霉素 24 小时浓度-时间曲线下面积(AUC)与谷浓度的相关性:一项临床药代动力学研究。
Int J Infect Dis. 2020 Mar;92:151-159. doi: 10.1016/j.ijid.2019.12.036. Epub 2020 Jan 11.